Clearwater Analytics to Go Private in $8.4 Billion Sale
Clearwater Analytics selling to Permira & Warburg Pincus for $8.4B. Shareholders get $24.55/share. Going private to focus on AI.
NOTRELOAD AI
Rocket Lab Secures $816M Contract to Build Defense Satellites
Rocket Lab secures $816M contract to build 18 missile-defense satellites for U.S. Space Force, its largest deal yet, totaling $1.3B in awards.
FDA Approves New Heart Drug MYQORZO for Obstructive HCM
The FDA has approved Cytokinetics' MYQORZO (aficamten), a groundbreaking treatment for adults with symptomatic obstructive hypertrophic cardiomyopathy to improve heart function and reduce symptoms.
Trump Administration Secures Drug Price Cuts from Nine Major Pharmaceutical Companies
Nine pharmaceutical giants including Merck and GSK agree to slash U.S. drug prices to match other wealthy nations under new Trump administration deals, offering discounts up to 70%.
Disc Medicine Stock Drops Amid FDA Official's Questions on Drug Effectiveness
Disc Medicine (IRON) shares fall 14% after FDA official questions bitopertin's effectiveness for rare blood disorder, though analysts maintain buy ratings and approval pathway optimism.
BlackBerry Shares Drop Despite Profit as QNX Growth Concerns Mount
BlackBerry stock fell over 11% despite Q3 profit and raised guidance, as investors worry about slowing growth at its key QNX embedded software division.